Clinical Trials Logo

Non-disabling Stroke clinical trials

View clinical trials related to Non-disabling Stroke.

Filter by:
  • None
  • Page 1

NCT ID: NCT04945174 Recruiting - Clinical trials for Transient Ischemic Attack

Stroke School -Including Physical Exercise, Patient Education and Individual Follow-up Sessions

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

In a randomized controlled trial the effect of 12 weeks of cross-sectorial physical exercise combined with patient education and individual follow-up session is investigated in patients with minor stroke or non-disabling stroke.

NCT ID: NCT03004820 Completed - Clinical trials for Transient Ischemic Attack

Prevention of Ischemic Conditions in Non-disabling Stroke/Transient Ischemic Attack With Remote Ischemic Conditioning

PICNIC-ONE
Start date: December 6, 2016
Phase: N/A
Study type: Interventional

This is a single-arm, open-labeled and phase II futility study. Application of Remote ischemic conditioning (RIC) as an adjunctive therapy to medication were involved in the study. The study is to test whether RIC is effective in preventing ischemic evens after a minor ischemic stroke/transient ischemic attack within 3 months and to explore the safety and compliance of chronic RIC. Medication strategy is based on physician's best judgement.

NCT ID: NCT00885456 Completed - Clinical trials for Transient Ischemic Attack

Program of Rehabilitative Exercise and Education to Avert Vascular Events After Non-disabling Stroke or Transient Ischemic Attack: A Multi-site RCT

PREVENT
Start date: October 30, 2011
Phase: Phase 2
Study type: Interventional

The objective of the Program of Rehabilitative Exercise and Education to avert Vascular Events after Non-disabling stroke and Transient ischemic attack (PREVENT) Trial is to determine whether the timely delivery of secondary stroke prevention strategies will reduce modifiable vascular risk factors in two groups of people who have survived NDS or TIA. One group will receive a comprehensive education and exercise program (PREVENT); the other group will receive usual care (USUAL CARE). We will measure modifiable vascular risk factors in both groups. We will also compare the effects of PREVENT vs USUAL CARE on exercise capacity, walking endurance, and daily physical activity. In addition, we will compare thinking ability, depression, achievement of personal goals for healthy behavior, and health-related goal attainment and health-related quality of life. Finally, we will compare outcomes in urban and rural settings as well as costs of the PREVENT program and USUAL CARE in order to assess sustainability of the PREVENT program.